1. Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS. Issue 1 (March 2017) Authors: Cull, G; Hall, D; Fabis-Pedrini, MJ; Carroll, WM; Forster, L; Robins, F; Ghassemifar, R; Crosbie, C; Walters, S; James, I; Augustson, B; Kermode, AK Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 3:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS03.6.A Rituximab in primary CNS lymphoma - long term follow-up of the phase III HOVON 105/ALLG NHL 24 Study. (5th September 2022) Authors: Bromberg, J E C; Issa, S; van der Holt, B; Minnema, M C; Seute, T; Durian, M F; Cull, G; van der Poel, M W M; Stevens, W B C; Zijlstra, J M; Nijland, M; Mason, K D; Beeker, A; Brandsma, D; van den Bent, M J; Gonzalez, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 2 Page Start: ii12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OS2.5 Effect of rituximab in primary central nervous system lymphoma - results of the randomized phase III HOVON 105/ALLG NHL 24 study. (19th September 2018) Authors: Bromberg, J E C; Issa, S; Bakunina, K; Minnema, M C; Seute, T; Cull, G; van den Bent, M J; Gonzales, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OS2.5 Effect of rituximab in primary central nervous system lymphoma - results of the randomized phase III HOVON 105/ALLG NHL 24 study. (19th September 2018) Authors: Bromberg, J E C; Issa, S; Bakunina, K; Minnema, M C; Seute, T; Cull, G; van den Bent, M J; Gonzales, M; de Jong, D; Doorduijn, J K Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗